1627. Vaccine Prevention of Varicella Zoster Virus Disease Achieved; Where Do We Go from Here?
Session: Symposium: Vaccines Against Herpesviruses
Friday, October 5, 2018: 2:25 PM
Room: S 305-314
Judith Breuer, MBBS, MD, FRCPath, Division of Infection and Immunity, Professor of Virology UCL, London, United Kingdom

Professor of Virology and Co-Director of the Division of Infection and Immunity at UCL, and Consultant Clinical Virologist at Great Ormond Street Hospital for Children. My research interests include the pathogenesis and spread of viral infections, particularly alphaherpesviruses. I am a world leader in the pathobiology of varicella zoster virus and its vaccines, and have recently discovered the viral transcript responsible for maintaining latency of this virus. Most recently I have applied novel technologies to whole genome sequencing of many viruses as well as hard-to-grow bacteria such as Mycobacterium tuberculosis and Chlamydia trachomatis directly from clinical samples. I have also led on pathogen discovery by metagenomics and RNA seq methodologies in patients with encephalitides of unknown origin, establishing the only UK clinical service in this area. I am an expert on vaccines and vaccine preventable diseases, a member of the UK Joint committee on Vaccines and Immunisations and Chair of the subcommittees on Human Papillomavirus and Varicella Zoster virus vaccines.


Disclosures:

J. Breuer, None

See more of: Vaccines Against Herpesviruses
See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.